Biomea Fusion, Inc. (BMEA) stock

BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$0.56−0.05 (-7.89%)

Close on Nov 12, 2026Market cap $40.79MP/E –Yield –

Biomea Fusion operating margin

Operating margin is operating income as a percentage of revenue.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2022	Sep 30, 2022	-14.2%	–
Q1 FY2022	Mar 31, 2022	-1.5%	–
Q1 FY2021	Mar 31, 2021	-0.5%	–

See a number that looks wrong?